Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Effects of AS01B, Ipilimumab, and Nivolumab in Patients with Advanced Melanoma

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium
  • Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

    Recruiting

    2 1 1
    Investigated drugs:
    Austria Bulgaria Germany Hungary Poland Romania +2
  • Study of NVL-655 for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with ALK Mutation

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study of ABTL0812, Irinotecan, and Temozolomide for Children with Relapsed or Refractory Neuroblastoma and Other Solid Tumors

    Recruiting

    1 1 1 1
    Investigated diseases:
    Spain
  • Study on Repotrectinib for Children and Young Adults with Advanced Solid Tumors with ALK, ROS1, or NTRK1-3 Alterations

    Recruiting

    1 1 1
    Investigated drugs:
    Denmark France Italy Spain
  • Study of E7386 and Lenvatinib for Patients with Liver, Colon, Endometrial, or Other Solid Tumors

    Recruiting

    1 1 1 1
    Denmark France Italy Spain
  • Study on the Effects of Removing Dexamethasone from Premedication in Paclitaxel Treatment for Patients with Solid Tumors

    Recruiting

    3 1 1 1
    Investigated diseases:
    The Netherlands
  • Study on Long-Term Safety of Trastuzumab Deruxtecan for Patients with Advanced HER2-Positive or HER2-Mutated Solid Tumors

    Recruiting

    3 1 1
    Investigated drugs:
    Belgium France Italy Spain
  • Study on the Safety and Efficacy of Tretinoin with Radiation Therapy for Patients with Oligometastatic Solid Cancer

    Recruiting

    1 1 1 1
    Investigated drugs:
    France
  • Study on the Safety of RP-6306 Alone or with RP-3500 or Debio 0123 for Patients with Advanced Solid Tumors

    Recruiting

    1 1 1
    Denmark France The Netherlands Spain